Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-07-18
1991-12-10
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514375, 546270, 548221, C07D26358, A61K 3142
Patent
active
050718630
ABSTRACT:
Certain 6-aryl- or 6-heteroaryl- alkylaminobenzoxazolones, and their pharmaceutically-acceptable salts, are dual inhibitors of lipoxygenase and cyclooxygenase enzymes, and so are useful as antiallergy and antiinflammatory agents.
REFERENCES:
patent: 3256293 (1966-06-01), Baker et al.
patent: 3657265 (1972-04-01), Kober
patent: 3929817 (1975-12-01), Draber
patent: 4227915 (1980-10-01), D'Amico
patent: 4835166 (1989-05-01), Kitaura et al.
patent: 4904685 (1990-02-01), Kitaura et al.
patent: 5006541 (1991-04-01), Kitaura
Clark et al., Jour. Am. Chem. Soc., vol. 80, pp. 1662-1664, (1958).
Ito Fumitaka
Mano Takashi
Nakane Masami
Daus Donald G.
Lumb J. Trevor
Olson A. Dean
Pfizer Inc.
Richardson Peter C.
LandOfFree
4,5,6,7-trisubstituted benzoxazolones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4,5,6,7-trisubstituted benzoxazolones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4,5,6,7-trisubstituted benzoxazolones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1040911